2024 Medicare Physician Fee Schedule Payment and Policy Updates
Course Description
Learning Objectives
- Adapt to requirements for the MIPS Values Pathways program.
- Understand telehealth services after the Federal COVID-19 Public Health Emergency.
- Implement coding changes impacting neurology in 2024.
Date of Release
December 20, 2023 - Recording
Confidentiality of Data
Faculty & Disclosures
Director of Epilepsy
Children's Hospital of Richmond
Associate Professor
Virginia Commonwealth University
*Dr. Zecavati has received honoraria for speaking roles from the American Academy of Neurology (AAN) and American Medical Association (AMA).
Meghan A. Ward, MD, FAAN, FAES
Epileptologist
Hartford Healthcare
Assistant Professor
University of Connecticut School of Medicine
*Dr. Ward has received honoraria for speaking roles from the AAN and for serving as an AAN advisor to the AMA Relative Value Scale Update Committee.
Daniel Ackerman, MD, FAAN
St. Luke’s University Health Network, Lewis Katz School of Medicine at Temple University
Vice Chairman, Department of Neurology
Program Director, Vascular Neurology Fellowship
*Dr. Ackerman has received honoraria for speaking roles from the AAN.
Planners & Disclosures
Brad C. Klein, MD, MDA, FAAN
Neurologist, Abington Neurological Associates
*Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC.
Luana Ciccarelli, CPC, CRC
Associate Director Medical Economics and Practice
American Academy of Neurology
**Ms. Ciccarelli has nothing to disclose.
Matt Kershner, MPA
Director of Regulatory Affairs and Policy
American Academy of Neurology
*Mr. Kershner has nothing to disclose.
Michaela Read
Telehealth and Practice Program Manager
American Academy of Neurology
*Ms. Read has nothing to disclose.
Meghan Eigenbrod, MPH
Care Delivery Program Manager
American Academy of Neurology
*Ms. Eigenbrod has nothing to disclose.
Desiree Cremeen, MA
Senior Payer Relations and Coverage Program Manager
American Academy of Neurology
*Ms. Cremeen has nothing to disclose.
*Relationship Disclosure